VirusGEN® Transfection Complex Stabilizer: Scale AAV Production With Peace Of Mind

Scaling up Adeno-Associated Virus (AAV) production for clinical and commercial use presents significant challenges, especially in maintaining process consistency and efficiency in large bioreactors. Managing transfection complex stability and volume during upstream Good Manufacturing Practice (GMP) operations can be a major bottleneck.

The VirusGEN® Transfection Complex Stabilizer is designed to simplify your AAV scale-up. This first-of-its-kind stabilizer significantly extends the window for using prepared transfection complexes from mere minutes to up to three hours. It also dramatically reduces the required complex volume by over half, down to just 2% of the total culture volume, without compromising viral titer or capsid quality when used alongside TransIT-VirusGEN® and RevIT™ AAV Enhancer.

Transform your upstream process and enable smoother, more flexible large-scale AAV production. Download the brochure today to learn how extending complex stability and reducing volumes can optimize your AAV manufacturing workflow.